11 September 2007 - Whistleblower protection: the experience of the United Kingdom
with Guy Dehn, Director, Public Concern at Work.
Guy Dehn is the director of the whistleblowing charity, Public Concern at Work. He leads the charity’s three activities, which are i) Providing free legal advice for individuals concerned about wrongdoing at work but who are unsure whether or how to raise the matter; ii) Delivering professional support for organisations; and iii) Promoting the public interest in policy and the law. He was closely involved in settling the scope and detail of the Public Interest Disclosure Act 1998 and advises on whistleblowing laws abroad. Prior to setting up the charity in 1993, he worked for seven years in the consumer field. He is a practising barrister and a trustee of the Allen Lane Foundation.
Further reading
> Dehn, G and R Calland, Whistleblowing - the State of the Art (The Role of the Individual, Organisations, the State, the Media, the Law and Civil Society), in “Whistleblowing Around the World; Law, Culture and Practice”, Public Concern at Work and Open Democracy Advice Centre, 2004. (PDF, 131 kb)
21 May 2007: Good Governance in the Pharmaceutical System: Why it is a Matter of Life and Death?
with Dr Jillian Clare Cohen (Assistant Professor at the Leslie Dan Faculty of Pharmacy, University of Toronto)
Dr. Jillian Clare Cohen is the Director of the Comparative Program on Health and Society. She is also an Assistant Professor at the Leslie Dan Faculty of Pharmacy and an advisory board member of the Centre for International Health, at the University of Toronto. Her research and teaching are focused on drug access issues for the global poor, the comparative politics of international pharmaceutical policy, and ethics and corruption in pharmaceutical systems. Prior to joining the University of Toronto, she worked on pharmaceutical policy for UNICEF, the World Bank and the WHO. She has also been a consultant for a number of governments, international organizations and aid agencies on pharmaceutical policy issues, on topics like regulation, corruption, and drug access. Most recently she has contributed a chapter on pharmaceutical governance for a forthcoming World Bank edited volume on sectoral approaches to fighting corruption (cf. further reading) and a 2007 WHO study on "Measuring Transparency in Medicines Registration, Selection and Procurement".
Further reading
> Download Dr Cohen's presentation as PDF (328 kb)
> Korruption kostet leben | Basler Zeitung | Tuesday, 22 Mai 2007 | page 31 | Download as PDF (232 kb)
> Tackling Corruption in the Pharmaceutical Systems Worldwide with Courage and Conviction by JC Cohen, M Mrazek and L Hawkins, Clinical Pharmacology & Therapeutics, vol 81, no 3 (March 2007), pp 445-449 Download as PDF (84 kb)
> Corruption and Pharmaceuticals: Strengthening Good Governance to Improve Access by JC Cohen, M Mrazek and L Hawkins, in "The Many Faces of Corruption: Tracking Vulnerabilities at the Sector Level", ed., J. Edgardo Campos and Sanjay Pradhan, Poverty Reduction and Economic Management, World Bank (February 2007) Download as PDF (196 kb)


